These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Effect of long-term testosterone therapy on the masculation of hypogonadal men]. Shi YF Zhonghua Yi Xue Za Zhi; 1989 Oct; 69(10):582-4. PubMed ID: 2620268 [No Abstract] [Full Text] [Related]
3. Testosterone and depression in men. Amiaz R; Seidman SN Curr Opin Endocrinol Diabetes Obes; 2008 Jun; 15(3):278-83. PubMed ID: 18438177 [TBL] [Abstract][Full Text] [Related]
4. [Late-onset hypogonadism in men: uncertain disease entity and reservations regarding treatment with testosterone]. Nieuwenhuijzen Kruseman AC Ned Tijdschr Geneeskd; 2006 Sep; 150(35):1925-8. PubMed ID: 16999276 [TBL] [Abstract][Full Text] [Related]
6. Should hypogonadal men with prostate cancer receive testosterone? Morgentaler A; Morales A J Urol; 2010 Oct; 184(4):1257-60. PubMed ID: 20723918 [No Abstract] [Full Text] [Related]
7. Androgel. Med Lett Drugs Ther; 2000 Jun; 42(1080):49-51. PubMed ID: 10859732 [No Abstract] [Full Text] [Related]
8. The role of accurate testosterone testing in the treatment and management of male hypogonadism. Dobs AS Steroids; 2008 Dec; 73(13):1305-10. PubMed ID: 18639568 [TBL] [Abstract][Full Text] [Related]
10. Response to: Efficacy of changing testosterone gel preparations (Androgel or Testim) among suboptimally responsive hypogonadal men. Morgentaler A Int J Impot Res; 2008; 20(3):331; author reply 332. PubMed ID: 18475269 [No Abstract] [Full Text] [Related]
11. Testosterone replacement therapy for the primary care physician. Casey RW; Barkin J Can J Urol; 2008 Aug; 15 Suppl 1():71-7; discussion 77. PubMed ID: 18700068 [TBL] [Abstract][Full Text] [Related]
12. Testosterone supplementation for hypogonadal men by the nasal route. Mattern C; Hoffmann C; Morley JE; Badiu C Aging Male; 2008 Dec; 11(4):171-8. PubMed ID: 19172548 [TBL] [Abstract][Full Text] [Related]
13. The management of hypogonadism in aging male patients. Sharma V; Perros P Postgrad Med; 2009 Jan; 121(1):113-21. PubMed ID: 19179819 [TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy. Coward RM; Simhan J; Carson CC BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450 [TBL] [Abstract][Full Text] [Related]
16. Editorial comment: hypogonadism among HIV-infected men--a common condition. Crum-Cianflone NF AIDS Read; 2006 Jul; 16(7):346-7. PubMed ID: 16874914 [No Abstract] [Full Text] [Related]
17. Effect of vardenafil on endothelial progenitor cells in hypogonadotrophic hypogonadal patients: role of testosterone treatment. Foresta C; Di Mambro A; Caretta N; De Toni L; Zuccarello D; Ferlin A Clin Endocrinol (Oxf); 2009 Sep; 71(3):412-6. PubMed ID: 19094070 [TBL] [Abstract][Full Text] [Related]
18. [Analysis of the statues of patients visiting our specialized clinic for hypogonadal men: 5-year experience]. Kawa G; Taniguchi H; Kinoshita H; Matsuda T Hinyokika Kiyo; 2009 Feb; 55(2):87-92. PubMed ID: 19301613 [TBL] [Abstract][Full Text] [Related]
19. [Testosterone replacement in hypogonadotropic hypogonadal young male improves insulin sensitivity]. Mao JF; Wu XY; Li NS; Lu SY; Jing ZM; Shi YF Zhonghua Yi Xue Za Zhi; 2008 Sep; 88(36):2550-2. PubMed ID: 19080648 [TBL] [Abstract][Full Text] [Related]
20. Clinical practice guidelines for screening and monitoring male patients receiving testosterone supplementation therapy. Morales A; Bain J; Ruijs A; Chapdelaine A; Tremblay RR Int J Impot Res; 1996 Jun; 8(2):95-7. PubMed ID: 8858399 [No Abstract] [Full Text] [Related] [Next] [New Search]